ALK

Over 70 senior leaders from across ALK met face to face this week in Denmark. 🗺️ In a global organisation like ours, meeting up physically to spend time together is important and highly valuable. Our annual two-day senior leadership meetings play a significant role in ensuring that we continuously review what’s working and adjust the direction for the years ahead. At the same time, they are key to strengthening relationships across functions and borders to the benefit of our teams, business and people living with allergy. Below is a snapshot of our global senior leadership team, connected across borders and united in our mission to help children and adults worldwide living with the burden of allergy.

Bee stings can cause severe allergic reactions – but did you know that bee venom is also what enables us to help those living with insect venom allergy? 🐝 Affecting millions of people worldwide, insect venom allergy can lead to potentially life-threatening reactions, such as an anaphylactic shock, if stung by a bee or a wasp. By carefully collecting tiny amounts of venom from these insects, we at ALK work to provide innovative treatment solutions for these people to help them regain confidence in their everyday lives. On this year’s #WorldBeeDay, we give you a peek behind the scenes at ALK to see how we work with beekeepers to collect bee venom without harming the insects, and then carefully extract and process it. A ‘hive five’ for the busy little pollinators out there, helping us help more people with allergy worldwide.✋🐝 And thank you to United Nations for shining an important light on these little creatures and the importance of protecting and enhancing their habitats, improving their abundance and diversity, and supporting the sustainable development of beekeeping. Watch the video to follow the journey from nature to medicine.

75,000 times thank you! To all of you reading, liking, sharing, commenting, and connecting with us here on LinkedIn. 💙 Whether you’ve been following us for years or just joined the profile, we hope you’re learning a lot about allergy and getting the information you’re seeking about the condition as well as our workplace. If you’re new to the profile, here’s what you can expect: 🔵 Information on allergy as a chronic disease and how it impacts daily life for millions of people worldwide. 🔵 Behind-the-scenes updates from ALK – from science in action to innovative projects advancing our mission to help more people with allergy. 🔵 People stories and career journeys from our collaborative, purpose-driven workplace – plus opportunities to join our teams. Tell us what you’d like to see more of in the comments, explore ALK.net to learn more – and if you’re not already part of our community, don’t forget to hit ‘Follow’ to join us!

Allergies know no borders. Neither does collaboration. 🌍 This week, we were honoured to welcome Dr. Motohiro Ebisawa to our headquarters in Denmark. As a world-renowned allergy scientist from Japan, Dr. Ebisawa joined representatives of our medical and scientific teams for an informal, expert-to-expert exchange particularly focusing on food allergy. The purpose of the visit was to exchange perspectives from Japan and Europe to deepen our shared allergy understanding and discuss how scientific insights might translate into better outcomes for people living with these potentially life-threatening allergic conditions across regions. International collaboration is central to our scientific approach at ALK, and dialogues like this help ensure our research reflects the diverse realities of patients and clinicians worldwide. Thank you, Dr. Ebisawa, for the visit and the valuable and inspiring conversations. We look forward to continuing our scientific and collaborative efforts in exploring new avenues to help people living with food allergy worldwide.

Real progress is built on thousands of small wins. 💪 At ALK, we turn everyday ideas into better ways of working – and celebrate along the way. 🏆 Operational excellence (OPEX) is part of the culture in our global Product Supply function and each year, colleagues who have significantly contributed to optimisations are nominated for the OPEX Award across five categories: cost, delivery, people, safety & sustainability and quality. This year, the improvements and innovations made were so notable that several categories ended in ties. Winners were selected by our internal OPEX network focusing on replication potential, team effort and measurable impact of the project. From cutting single‑use waste and lead times to sharpening batch documentation, ensuring quicker sterile setups and introducing faster onboarding, these initiatives all show how curiosity and collaboration can translate into meaningful results. Explore the winning projects in the slides below – maybe there’s inspiration to find for your own optimisation or improvement efforts? Congratulations to all winners – and thank you to everyone championing continuous improvements at ALK. 👏

High pollen levels in many countries right now bring sniffles and sleepless nights to some families. A new digital tool from ALK aims to ease their daily routines. At ALK, we’re working every day to help more children and adults with allergy worldwide – also through developing practical, digital tools to make life with allergy just a bit easier. Colleagues from across our teams and countries recently launched a feature in our allergy app, klarify, helping parents track their children’s respiratory allergy symptoms, its daily impact, and potential medicines used – and turning the information into a clear, doctor-ready report. Already available in three markets and with more to follow, the tool aims to help families and clinicians have more efficient conversations about children’s allergy symptoms and potential next steps. Frederik Andreas Jacobsen, Senior Director of Digital Customer Engagement & Digital Excellence at ALK, says: “With this tool, we hope to help parents get the most out of their doctor’s consultations and more confident asking for early help. Built in-house in close collaboration with caregivers and healthcare professionals, this new function is part of ALK’s broader support for families – one that remains useful beyond pollen season to support children with e.g. house dust mite allergy as well.” We remain committed to finding innovative ways to help even more people and families affected by the chronic condition that allergy is. 💪 Congratulations to the team behind this launch! 📸: Our colleagues Tatiana Lyng Obel and Frederik Andreas Jacobsen during our recent internal launch celebration. 🧁

We’ve set the pace for 2026, announcing a strong set of Q1 results – and an upgrade of our expectations for the full-year. 💪 Our CEO Peter Halling says: “Our continued double-digit growth in Q1 reflects our firm commitment at ALK to improve the lives of those living with allergy worldwide. Through a steady focus on expanding patient access, improving operational excellence, and continuously driving innovation across both existing and related disease areas, we have delivered strong results, underscored our scientific capabilities and reinforced our leadership in the specialty allergy field. We remain well positioned to deliver sustainable value both today and in the years ahead.” Find some of our key numbers below – and visit ALK.net to read the full report. 👈

True to his role as Chief Financial Officer at ALK, Claus Steensen Sølje loves numbers – and he’s also passionate about a certain kind of four-wheelers. 👇 Since childhood, Claus has enjoyed counting money, and for almost three years he’s been the CFO at ALK, driving several positive changes across our global company. He takes his responsibility seriously, keeps a steady hand on the key to our finances and uses his interest in data to gauge the business’ health and ensure that ALK remains fit to help even more people with allergy. Somewhere between cash flows and quarterly closes, Claus also sneaks in the occasional four‑wheeler ride. Are you curious to find out which kind of four-wheelers he’s so fond of – and who Claus is behind his title? Watch the teaser video below and visit our career site to see his full story: https://lnkd.in/e2cJVPh7. 📽️

What if the immune system could ‘forget’ allergies? New research from ALK and McMaster University points to how this may be possible. 🌍🔬 And what better day to dive into this new study, than on #WorldImmunologyDay? Recently published in the high-impact scientific journal, Science Immunology, this new paper demonstrates that the immune system’s allergen‑specific memory B cells – previously identified as ‘the home of allergy in the body’ – can potentially be nudged to reduce allergic responses, lessening allergic symptoms for patients. More specifically, the study highlights that: 🔵 Under the right conditions, memory B cells can change course, reduce their production of allergy-promoting IgE antibodies and shift toward producing the protective IgG antibodies instead. 🔵 By blocking two specific key immune signaling molecules (IL‑4 and IL‑13), allergic memory becomes more flexible – revealing mechanisms that could potentially be targeted in future treatments to change the course of allergic disease. 🔵 Some of the pathways implicated in this work are already touched by existing therapies for severe asthma and eczema, hinting at future ways to ‘retrain’ allergic memory for longer-lasting benefit. Peter Sejer Andersen, Senior Vice President of Global Research and Drug Discovery at ALK, says: “This study reflects ALK’s commitment to high‑impact translational science, to continuously deepening our understanding allergies, and to global collaborations rethinking what’s possible in allergy care. It has the potential of changing the way we think about allergies and how patients are helped in the future.” Congratulations to the ALK and McMaster Faculty of Health Sciences teams who contributed to this important work. 🎉 And thanks to European Academy of Allergy and Clinical Immunology - EAACI for shedding a light on the important field of immunology, continuously enhancing our understanding of the immune system. 📸 Pictured (left to right): Lars Harder, Jette Skovsgaard, Niels Peter Hell Knudsen, Gitte Kongsgaard Koed, Anders Lund, Gitte Lund, and Peter Sejer Andersen.

Cue the confetti: it’s time for our annual celebration of six colleagues who bring ALK’s values to life – meet this year’s Cultural Ambassadors. 🎉 Our innovative and welcoming culture at ALK thrives thanks to dedicated and proactive colleagues who keep people living with allergies at the centre, speak up when they see opportunities for improvement, and work to build understanding across teams and borders. Each year, employees who exemplify this spirit are nominated by their colleagues, endorsed by local leaders and confirmed by our executive leadership team. This year’s ambassadors are: Magda Morales, United States, Joanna Bucka, Poland, Hampus Kiotseridis, Denmark, Ester Escobar González, Spain, Magnus Lindqvist, Sweden, Zhigang Li, China. Please join us in congratulating the award winners in the comments below. 💙 And swipe through the slides to see why each ambassador was nominated.